Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,230 | -23,763 | -34,515 | -48,207 | -57,855 |
| Depreciation Amortization | 1,722 | 1,789 | 1,451 | 1,317 | 1,604 |
| Other Working Capital | -2,261 | 206 | -1,448 | -2,128 | -1,353 |
| Other Operating Activity | 1,468 | 1,755 | 3,449 | 6,654 | 4,743 |
| Operating Cash Flow | $-15,301 | $-20,013 | $-31,063 | $-42,364 | $-52,861 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,084 | 4,953 | 37,766 | -26,325 | 34,127 |
| PPE Investments | -184 | -28 | -594 | -1,312 | -600 |
| Investing Cash Flow | $6,900 | $4,925 | $37,172 | $-27,637 | $33,527 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 52,343 | 9,736 |
| Debt Repayment | -9,083 | -8,000 | -4,667 | N/A | -5,202 |
| Common Stock Issued | 25,226 | 9,336 | 429 | 361 | 163 |
| Financing Cash Flow | $16,143 | $1,336 | $-4,238 | $52,704 | $4,697 |
| Beginning Cash Position | 9,210 | 22,962 | 21,091 | 38,388 | 53,025 |
| End Cash Position | 16,952 | 9,210 | 22,962 | 21,091 | 38,388 |
| Net Cash Flow | $7,742 | $-13,752 | $1,871 | $-17,297 | $-14,637 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,301 | -20,013 | -31,063 | -42,364 | -52,861 |
| Capital Expenditure | -202 | -79 | -594 | -1,312 | -600 |
| Free Cash Flow | -15,503 | -20,092 | -31,657 | -43,676 | -53,461 |